Status:
COMPLETED
A Double-blind Study of Controlled Release OROS Hydromorphone Compared to Placebo in Patients With Chronic Osteoarthritis (OA) Pain
Lead Sponsor:
Mallinckrodt
Conditions:
Chronic Pain
Eligibility:
All Genders
30-80 years
Phase:
PHASE3
Brief Summary
To evaluate the efficacy of OROS Hydromorphone in reducing moderate to severe chronic pain in patients with Osteoarthritis (OA) Pain
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Primary clinic diagnosis of osteoarthritis pain of the hip or of the knee for at least 6 months
- Patients required daily opioid medication to treat their chronic osteoarthritis pain
- Exclusion Criteria
- Joint replacement of the hip or of the knee that is the primary source of osteoarthritis Pain
- History drug or alcohol abuse
- Fibromyalgia
- Patients who have major depression or anxiety
- Women who are pregnant or breast feeding
Exclusion
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
343 Patients enrolled
Trial Details
Trial ID
NCT00631319
Start Date
February 1 2008
End Date
June 1 2009
Last Update
September 16 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.